Comments on: Transradial Approach for Noncoronary Interventions: A Single-Center Review of Safety and Feasibility in the First 1,500 Cases

被引：2
|
作者：
Turba, Ulku Cenk [1 ]
Masrani, Abdulrahman [1 ]
Arslan, Bulent [1 ]
机构：
[1] Rush Univ, Med Ctr, Div Intervent Radiol, Dept Radiol,Sect Vasc Intervent, 1725 West Harrison St,Suite 450, Chicago, IL 60612 USA
来源：
JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY | 2016年 / 27卷 / 06期
关键词：
D O I：
10.1016/j.jvir.2016.02.034
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
引用
收藏
页码：937 / 937
页数：1
相关论文
共 35 条
  • [31] Effectiveness and safety of angiogenesis inhibitors combined with PD-1/PD-L1 blockades in the first-line treatment of patients with advanced hepatocellular carcinoma: A single-center retrospective study
    Xu, Jing
    Wang, Xin
    Jia, Zhenya
    Sun, Guoping
    MEDICINE, 2025, 104 (11)
  • [32] SORAFENIB IN THE PALLIATIVE TREATMENT OF HEPATOCELLULAR CARCINOMA (HCC) DEVELOPED IN NON-FIBROTIC LIVER (F0-F1): SAFETY, EFFICACY. SINGLE-CENTER SERIE OF 33 CASES
    Blanc, J. -F.
    Gauthier, C.
    Possenti, L.
    Lepicard, P.
    Castain, C.
    Le-Bail, B.
    Trillaud, H.
    JOURNAL OF HEPATOLOGY, 2012, 56 : S389 - S389
  • [33] Standardized Minimalistic Transfemoral Transcatheter Aortic Valve Replacement (TAVR) Using the SAPIEN 3 Device: Stepwise Description, Feasibility, and Safety from a Large Consecutive Single-Center Single-Operator Cohort (vol 1, pg 169, 2017)
    Frangieh, Antonio H.
    Ott, Ilka
    Michel, Jonathan
    Shivaraju, Anupama
    Joner, Michael
    Mayr, N. Patrick
    Hengstenberg, Christian
    Husser, Oliver
    Pellegrini, Costanza
    Schunkert, Heribert
    Kastrati, Adnan
    Kasel, Albert Markus
    STRUCTURAL HEART-THE JOURNAL OF THE HEART TEAM, 2020, 4 (06): : W523 - W523
  • [34] Pharmacokinetics, Safety and Tolerability of Bencycloquidium Bromide, a Novel Selective Muscarinic M1/M3 Receptor Antagonist, After Single and Multiple Intranasal Doses in Healthy Chinese SubjectsAn Open-Label, Single-Center, First-in-Human Study
    Luning Sun
    Li Ding
    Yongqing Wang
    Wenjia Zhou
    Zhengyu Yan
    Weilin Sun
    Hongwen Zhang
    Ning Ou
    Xiaoping Chen
    Drugs in R&D, 2012, 12 (1) : 17 - 28
  • [35] Pharmacokinetics, Safety and Tolerability of Bencycloquidium Bromide, a Novel Selective Muscarinic M1/M3 Receptor Antagonist, After Single and Multiple Intranasal Doses in Healthy Chinese Subjects An Open-Label, Single-Center, First-in-Human Study
    Sun, Luning
    Ding, Li
    Wang, Yongqing
    Zhou, Wenjia
    Yan, Zhengyu
    Sun, Weilin
    Zhang, Hongwen
    Ou, Ning
    Chen, Xiaoping
    DRUGS IN R&D, 2012, 12 (01) : 17 - 28
1234